Research Article

Open Access
The TUDOR domain of SMN is an H3K79me1 histone mark reader
View ORCID ProfileOlivier Binda Correspondence email, Aimé Boris Kimenyi Ishimwe, Maxime Galloy, Karine Jacquet, View ORCID ProfileArmelle Corpet, View ORCID ProfileAmélie Fradet-Turcotte, Jocelyn Côté, View ORCID ProfilePatrick Lomonte Correspondence email
Olivier Binda
1Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France
2University of Ottawa, Faculty of Medicine, Department of Cellular and Molecular Medicine, Ontario, Canada
Roles: Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, Writing—review and editing
Aimé Boris Kimenyi Ishimwe
1Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France
Roles: Investigation
Maxime Galloy
3Université Laval Cancer Research Center, Université Laval, Québec, Canada; Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Québec, Canada; and Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, Canada
Roles: Investigation
Karine Jacquet
1Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France
Roles: Investigation
Armelle Corpet
1Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France
Roles: Conceptualization, Supervision
Amélie Fradet-Turcotte
3Université Laval Cancer Research Center, Université Laval, Québec, Canada; Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Québec, Canada; and Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, Canada
Roles: Supervision, Funding acquisition, Writing—original draft
Jocelyn Côté
2University of Ottawa, Faculty of Medicine, Department of Cellular and Molecular Medicine, Ontario, Canada
Roles: Conceptualization, Supervision, Funding acquisition
Patrick Lomonte
1Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France
Roles: Conceptualization, Supervision, Funding acquisition, Writing—original draft, Project administration
Published 7 March 2023. DOI: 10.26508/lsa.202201752

SMNTUDOR reads H3K79me1
Olivier Binda, Aimé Boris Kimenyi Ishimwe, Maxime Galloy, Karine Jacquet, Armelle Corpet, Amélie Fradet-Turcotte, Jocelyn Côté, Patrick Lomonte
Life Science Alliance Mar 2023, 6 (6) e202201752; DOI: 10.26508/lsa.202201752
In this Issue
Volume 6, No. 6
June 2023
Advertisement
Jump to section
Related Articles
- No related articles found.